Correlation Between Bavarian Nordic and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bavarian Nordic and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bavarian Nordic and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bavarian Nordic and Genmab AS, you can compare the effects of market volatilities on Bavarian Nordic and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bavarian Nordic with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bavarian Nordic and Genmab AS.

Diversification Opportunities for Bavarian Nordic and Genmab AS

0.86
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Bavarian and Genmab is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Bavarian Nordic and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Bavarian Nordic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bavarian Nordic are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Bavarian Nordic i.e., Bavarian Nordic and Genmab AS go up and down completely randomly.

Pair Corralation between Bavarian Nordic and Genmab AS

Assuming the 90 days trading horizon Bavarian Nordic is expected to under-perform the Genmab AS. In addition to that, Bavarian Nordic is 2.2 times more volatile than Genmab AS. It trades about -0.13 of its total potential returns per unit of risk. Genmab AS is currently generating about -0.2 per unit of volatility. If you would invest  186,950  in Genmab AS on September 2, 2024 and sell it today you would lose (34,350) from holding Genmab AS or give up 18.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Bavarian Nordic  vs.  Genmab AS

 Performance 
       Timeline  
Bavarian Nordic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bavarian Nordic has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Bavarian Nordic and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bavarian Nordic and Genmab AS

The main advantage of trading using opposite Bavarian Nordic and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bavarian Nordic position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Bavarian Nordic and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios